These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10981144)

  • 1. Angiotensin-converting enzyme inhibitors in antihypertensive therapy.
    Luft FC
    Curr Hypertens Rep; 2000 Apr; 2(2):165-6. PubMed ID: 10981144
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibitors: new hope for old drugs?
    Dvorak SR
    S D J Med; 2000 Aug; 53(8):333-4. PubMed ID: 10967940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of hypertension. Lasting organ protection moves into the foreground].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14738040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings].
    Lebedev AV; Kukushkin SK; Manoshkina EM; Shamarin VM; Deev AD
    Kardiologiia; 2003; 43(3):71-2. PubMed ID: 12913982
    [No Abstract]   [Full Text] [Related]  

  • 5. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS; Gassler JP
    Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
    [No Abstract]   [Full Text] [Related]  

  • 6. Ramipril: the better angiotensin-converting enzyme inhibitor?
    Gupta R
    Indian Heart J; 2008; 60(3):188-91. PubMed ID: 19240304
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
    Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE
    Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].
    Traut V
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292
    [No Abstract]   [Full Text] [Related]  

  • 10. CAPPP trial. Captopril Prevention Project.
    Gueyffier F; Boissel JP; Plouin PF
    Lancet; 1999 May; 353(9166):1795-6. PubMed ID: 10348014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
    Abuladze GV; Nebieridze MI; Narsiia EV; Erkomaishvili IG; Pipiia NG
    Georgian Med News; 2011 Jun; (195):37-40. PubMed ID: 21778538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of asymptomatic left ventricular dysfunction.
    Haas GJ
    Cleve Clin J Med; 2001 Mar; 68(3):249-55. PubMed ID: 11263853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of captopril in rheumatoid arthritis: combining treatment targets!
    Popa CD; van Riel PL
    Can J Cardiol; 2013 May; 29(5):639.e13. PubMed ID: 23541661
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis.
    Vidt DG
    Curr Hypertens Rep; 2001 Oct; 3(5):379-80. PubMed ID: 11551370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?].
    MMW Fortschr Med; 2003 Dec; 145(51-52):39. PubMed ID: 14974331
    [No Abstract]   [Full Text] [Related]  

  • 18. CAPPP trial. Captopril Prevention Project.
    Scheen AJ
    Lancet; 1999 May; 353(9166):1793-4; author reply 1795-6. PubMed ID: 10348010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study report: Hypertension therapy with organ protection. Piretanid and Ramipril: advantages with fixed combination].
    Fortschr Med Suppl; 1994; 164():3-15. PubMed ID: 16805053
    [No Abstract]   [Full Text] [Related]  

  • 20. CAPPP trial. Captopril Prevention Project.
    Messerli FH; Grossman E
    Lancet; 1999 May; 353(9166):1794-5; author reply 1795-6. PubMed ID: 10348012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.